<< Вернуться к списку статей журнала

Том 1 №2,3 1999 год - Нефрология и диализ

Апоптоз в патогенезе нефропатий

Цаликова Ф.Д.

Аннотация: Апоптоз, чаще называемый программированной смертью клетки, является энергетически активным, генетически контролируемым процессом, который избавляет организм от ненужных или поврежденных клеток [1]. Этот процесс впервые описан в 1972 г. Kerr под названием «программированная клеточная гибель» [22]. Происхождение самого термина относится к 1993 г., когда Greek предложил его в соответствии со смысловой ассоциацией со словом «листопад» [20].

Для цитирования: Цаликова Ф.Д. Апоптоз в патогенезе нефропатий. Нефрология и диализ. 1999. 1(2,3):127-130. doi:

Весь текст

Ключевые слова: апоптоз, гломерулосклероз, нефрит, нефропатия, почки

Список литературы:

1. Программированная клеточная гибель: под ред. проф. В.С.Новикова С.Пб: Наука, 1996; 276.
2. Baker A.J., Mooney A., Hughes J., Lombardi D., Johnson RJ., Savill J.: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest 1994; 94: 2105-2116.
3. Bissonnette R.P., Echeverri F., Mahoubi A., Green D.R.: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-554.
4. Bortner, C.D., Oldenberg N.B.E., and J.A. Cidlowski: The role of DNA fragmentation in apoptosis. Trends Cell Biol.1995; 5: 21-26.
5. Cavrieli Y., Y.Sherman, and S.A.Ben-Sasson: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J.Cell Biool. 1992; 119: 493-501.
6. Cohen J.J.: Apoptosis. Imunol. Today 1993; 14:126-130.
7. Coles H.S.R., Burne J.F., Raff M.C.: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal grwth factor. Development 1993; 118: 777-784.
8. Cummings M.C.: Increased p53 mRNA expression in liver and kidney apoptosis. Biochimica et Biophysica Acta.1996; 1315; 2: 100-4.
9. Duke R.C., Cohen J.J.: IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Limphokine Res 1986; 5: 289-294.
10. Earnshaw W.C.: Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 1995; 7: 337-343
11. Grantham J.J.: Polycystic kidney disease: huge kidneys, huge problems, huge progress. Transactions of the Am. Clin. and Climatological association 1996; 108: 165-70; discussion 170-2.
12. Grantham J.J.: The etiology, pathogenesis and treatment of autosomal dominant polycystic kidney disease: recent advanced. Amer. J. of Kidney Diseases 1996; 28: 6, 788-803.
13. Hamada T., Sasaguri T., Tanimoto A.: Apoptosis of human kidney 293 cells is promoted by polymerized cadmium- metallothionein. Biophysical Research Communications 1996; 219; 3::829-34.
14. Hamet P., Richard L., Dam T.V.: Apoptosis in target organs of hypertension. J.Hypertension 1995; 26; 4: 642-8.
15. Hammerman: Growth factors in renal development Seminars in Nephrology 1995; 15; 4: 291-9.
16. Harrison D.J.: Cell death in the diseased glomerulus. Histopathology 1988; 12: 679-683.
17. Healy А., M. Dempsey, C. Lally and M.P. Ryan: Apoptosis and necrosis: Mechanisms of cell death induced by Cyclospoprine A in a renal proximal tubular cell line. Kidney International, 1998; 54; 1955-1966.
18. Hitoshi Sugiyama, NaokiKashihara, Hirofumi Makino, Yasushi Yamasaki, and Zensuke Ota: Apoptosis in glomerular sclerosis. Kidney International, 1996; 49; 103-111.
19. Jan H., Carter C.E., Xu C.: Cadmium induced apoptosis in the urogenital organs of the male rat and its supression by helators. J. Toxicology and Environmental Health. 1997; 52; 2: 149-68.
20. John Savill: Apoptosis and the Kidney. J.Am.Soc Nephrol.1994; 5: 12-21.
21. Johnson R.J., Alpers C.E., Pruchno C., Schulze M., Baker P.J., Pritzl P., Couser W.G.: Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int.1989; 36: 780-789.
22. Kerr J.F.R., Wyllie A.H., Currie A.R.: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26:239-257.
23. Koury M.J., Bondurant M.C.: Eritropoetin retards DNA breakdown and prevents programmed death in eritroid progenitor cells. Science 1990; 246: 378-380.
24. Lemay S., Mao C., Singh A.K.: Cytokine gene expression in the MRL/lpr model of lupus nephritis. Kidney Int. 1996; 50; 1: 85-93.
25. Majno G. and Joris I.: Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 1995; 146: 3-15.
26. Ono H., Ono Y.: Nephrosclerosis and hypertension. Medical Clinics of North America 1997; 81; 6: 1273-88.
27. Raff M.C.: Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
28. Savill J., Smith J., Sarraf C., Ren Y., Abbott F., Rees A.J.: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Intern. 1992; 42: 924-936.
29. Sessa A., Ghiggeri G.M., Turco A.E.: Autosomal dominant polycystic kidney disease: clinical and genetic aspects. J. of Nephrology 1997; 10; 6: 295 - 310.
30. Shimizu A., Kitamura H., Masuda Y., Ishizaki M., Sugisaki Y., Yamanaka N.: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 1995; 47: 114-121.
31. Shimizu A., Kitamura H., Masuda Y.: Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am. J. of Pathology. 1997; 151; 5: 1231 - 9.
32. Solary E., Dubrez L., Eymin B.: The rolo of apoptosis in the pathogenesis and treatment of diseases. European Respiratory 1996; 9; 6: 1293-305.
33. Soto H., Mosquera J., Rodriguez-Iturbe B.: Apoptosis in proliferative glomerulonephritis: decreased apoptosis expression in LN. Nephrology, Dialisis, Transplantation 1997; 12; 2: 273-80.
34. Suda T., Takahashi T, Golstein P, Nagata S.: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
35. Susan E.Thomas, Takeshi F. Andoh, Raimund H. Pichler, Stuart J.Shankland, William G.Couser, William M.Bennett, and Richard J.Johnson: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney International. 1998; 53; 697-908.
36. Takemura T., Murakami K., Miyazoto H.: Expression of FaS ANTIGEN AND Bcl-2 in human glomerulonephritis. Kidney International 1995; 48; 6: 1886-92.
37. Wilfred Lieberthal and Jerrold S.Levine: Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injur.i Am.J.Physiol. 271 (Renal Fluid Electrolyte Physiol. 40):F477-F488, 1996.
38. Winysard P.J., Nauta J., Lirenman D.S.: Deregulation of cell survival in cystic and dysplastic renal development. Kidney International 1996, 49; 1: 135-46.
39. Woo D.: Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 1995; 333; 1: 56-7.
40. Wyllie A.H., Kerr J.F.R., Currie A.R.: Cell death: The significance of apoptosis Int Rev Cytol 1980; 68: 251-306.

Другие статьи по теме

• Преждевременный атеросклероз при хронической почечной недостаточности
• Характеристика необычных поствакцинальных осложнений со стороны почек и мочевыводящих путей (Обзор литературы)
• Использование лазерной корреляционной спектроскопии в качестве экспертной системы оценки эффективности проводимой терапии при заболеваниях почек у детей
• Нефропатия флебогипертензивного генеза и выбор метода лечения при варикоцеле у детей и подростков